Randomized, Placebo-controlled, Single Blind, Trial to Determine the Safety and Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
Phase of Trial: Phase I/II
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Ticagrelor (Primary)
- Indications Renal failure
- Focus Adverse reactions
- 24 Oct 2016 Planned End Date changed from 1 Mar 2017 to 1 Jun 2018.
- 24 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
- 14 Jan 2015 New trial record